Nicotinamide N-methyltransferase (NNMT) in health and disease. Cellular and Molecular Life Sciences, 78, 62416257
Cognitive Decline and Neurodegenerative Conditions Cognitive decline and neurodegenerative conditions show substantial preclinical evidence across multiple pathologies: Stroke models: BPC-157 given during reperfusion counteracted neuronal damage and produced full functional recovery in spatial memory, motor coordination, and balance tests Parkinsons models: MPTP-induced models showed reduced motor symptoms (tremor, rigidity, akinesia), protection of nigrostriatal dopaminergic neurons, and near-complete prevention of mortality Multiple sclerosis models: Cuprizone-induced demyelination resulted in significantly less brain damage and reduced clinical abnormalities when BPC-157 was given in drinking water or intragastrically Traumatic brain injury: Falling weight model studies demonstrated reduced hemorrhage, decreased brain lacerations and edema, and improved early outcomes These diverse models share common mechanisms
It helps give me energy and reduces food cravings Felt immediate results I use this along with tirzepeptide, and it has helped maintain my weight and a boost of energy
Ill go into each of these treatments in more detail in future articles and videos, but heres a quick summary
Platelet-rich plasma (PRP) therapy, for example, provides a mixture of autologous growth factors and cytokines and has more established clinical evidence for certain applications
)
)
)
